IC
Ikarian Capital, LLC cut its IRLA stake below 5%
Ikarian Capital, LLC reported owning 2.3% of IRulya Therapeutics Inc. (IRLA) (254,058 shares) in a Schedule 13G filed Nov 17, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 17, 2026
- Source
- Schedule 13G